News

Cards

  • Published on

    Ayman A Al Hayek, Samia H Sobki, Abdulghani H Al-Saeed, Wael M Alzahrani, Mohamed A Al Dawish

    Level of agreement and correlation between HbA1c with point-of-care or laboratory-based measurements

    en
    Access Now
    Restricted
  • Published on

    Gerald J Kost

    Public health education on point-of-care testing during public health crises

    en
    Access Now
    Restricted
  • Published on

    Jane Rhyu, Sylvia Lambrechts, Maria A Han, Matthew J Freeby

    Utilising point-of-care A1c testing to impact outcomes in primary care

    en
    Access Now
  • Published on

    Expert view on antibiotic misuse and CRP POCT

    en
    Access Now
    Restricted
  • Published on

    Joseph Benjamin Crocker, Stephen H Lynch, Anthony J Guarino, Kent Lewandrowski

    Impact of point-of-care testing on population health-based onsite testing adherence

    en
    Access Now
  • Published on

    Owen R, Wyckoff M, Rogers R

    Increasing access to diabetes care using mobile medicine

    en
    Access Now
  • Published on

    Deon Lingervelder, Hendrik Koffijberg, Ron Kusters, Maarten J IJzerman

    Health economic evidence of point-of-care testing: a systematic review

    en
    Access Now
  • Published on

    Sean D Currin, Mwawi S Gondwe, Nokthula B Mayindi, Shingirai Chipungu, Bongekile L Khoza, Stephen Tollman, June Fabian, Jaya A George, ARK Consortium

    Diagnostic accuracy of point-of-care albumin-creatinine ratio in a resource-limited setting

    en
    Access Now
  • Published on

    Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.

    Albuminuria testing in hypertension and diabetes

    en
    Access Now
  • Published on

    Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).

    ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease

    en
    Access Now
  • Published on

    Eun Hee Nah, Seon Cho, Suyoung Kim, Han Ik Cho

    Comparison of urine albumin-creatinine ratio point-of-care test and quantitative test in prediabetes and diabetes

    en
    Access Now
  • Published on

    Bernd Schultes, Susanne Emmerich, Andreas D Kistler, Badreddine Mecheri, Oliver Schnell, Gottfried Rudofsky

    Impact of albumin-creatinine ratio point-of-care testing on the diagnosis and management of diabetic kidney disease

    en
    Access Now
  • Published on

    Diabetic kidney disease, and chronic kidney disease attributed to diabetes, occurs in 20-40% of patients with diabetes. Acute kidney injury is also one of the most significant complications associated with COVID-19. Point-of-care testing for albumin-creatinine ratio is a valuable tool for monitoring at-risk patients, especially in combination with other comorbid parameters, such as HbA1c and lipids.

    ACR point-of-care testing for diabetic kidney disease

    en
    Access Now
    Certified Content
    Restricted
  • Published on

    The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.

    WHO guidelines on second-and third-line medicines and type of insulin for blood glucose control in diabetes

    en
    Access Now
  • Published on

    Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.

    Tackling drug-resistant infections globally: report and recommendations

    en
    Access Now
  • Published on

    The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.

    KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease

    en
    Access Now
  • Published on

    This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.

    IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing

    en
    Access Now
  • Published on

    This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.

    IDSA clinical practice guideline update on the management of seasonal influenza

    en
    Access Now